Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. - Wikidata - wikimedia - TriplyDB

Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.

Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.

http://www.wikidata.org/entity/Q36379309

about

Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?CD1d- and MR1-Restricted T Cells in Sepsis Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression.Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Impact of sepsis on CD4 T cell immunity Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.Persistent lymphopenia after diagnosis of sepsis predicts mortality.Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.The future of murine sepsis and trauma research models.Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.T cells from patients with Candida sepsis display a suppressive immunophenotype N-terminal pro-C-natriuretic peptide and cytokine kinetics in dogs with endotoxemia Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.Pathways mediating resolution of inflammation: when enough is too much.Immunotherapy of Fungal Infections.Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential.Pathogenic, immunologic, and clinical aspects of sepsis - update 2016.Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.Apoptosis-induced lymphopenia in sepsis and other severe injuries.Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients.Dying to protect: cell death and the control of T-cell homeostasis.Anti-PD-L1 peptide improves survival in sepsis.Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement.[Interleukin-7, a new immunoadjuvant for the treatment of septic shock].Future Directions and Molecular Basis of Ventilator Associated Pneumonia.Potential Immunotherapeutics for Immunosuppression in Sepsis.Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.Inhibition of MicroRNA-23b Attenuates Immunosuppression in Late Sepsis through NIK, TRAF1 and XIAP.The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery.Is There a Role for Hematopoietic Growth Factors During Sepsis?Year in review in Intensive Care Medicine 2014: II. ARDS, airway management, ventilation, adjuvants in sepsis, hepatic failure, symptoms assessment and management, palliative care and support for families, prognostication, organ donation, outcome, o Epidemiology and Immune Pathogenesis of Viral Sepsis

P2860

Q22306306-7C746D12-9F64-44FB-9415-F872FC9812A4 Q26796132-F9BDF45E-AA80-4A31-B1A1-EEB84D0897D9 Q26852697-228B9DCB-1F67-4C43-A753-734FCEBCF28F Q30356392-C3DA0A33-F82B-484E-82A6-86A9A3385681 Q33749945-12AF0BD1-AED0-4251-9C64-016E63E5D970 Q33828888-854C8D65-763F-43E8-8FEB-95C71FF1750C Q34341378-051C9ECF-9823-456D-91F2-BD360243BB15 Q35177535-DA336489-D335-4116-B806-4750785D15DD Q35184876-CB71F4DF-A5A5-4607-A6A1-B579DAF51D92 Q35546243-FF9B3569-3FAA-4CF8-AC4D-00E620612C86 Q36322341-1C9A7B2A-77EB-4F2F-8740-8E7C269C90E0 Q36410992-11CDCCA4-1068-42AE-8345-2FADD7DF2007 Q36480729-77344A86-E274-4BAA-87A9-CC2A8392250C Q36975341-3365D253-E293-4D56-A9DF-9A56506E56DC Q36997987-CB32F0AF-C764-4B98-B3AB-6C198C72543F Q37233354-8E4A13D3-AEF0-4DAF-A563-6F9F5E0C9F16 Q37563023-BC3C70FF-6052-4698-831B-5D22333F5581 Q37649004-C08CEF6C-64FA-4BCD-99BC-1944E61DD12B Q38116494-E072446B-8538-4BA5-AB58-E24DFAAF50AA Q38635409-9696F93D-4162-439D-B2DE-B8E3FD540094 Q38715255-64C12593-1E2A-4925-8035-1B6BA796C569 Q38830793-30456BAD-19C0-45D3-9F29-155C5C7D53DE Q38836832-26457045-E01B-49F3-91E9-E302A8B01BC0 Q38998292-C15AF1B8-3A74-4052-852F-5F24BC2AE53B Q39170358-D69FF2B9-7F03-4DC6-B6B0-1BE87BC4D832 Q39277476-013652D0-8192-45FC-9DF7-F69A20B60A0E Q40404109-2839D5D8-ED54-4FA3-BA52-3A79D3BF8B11 Q40526734-656771C8-E49B-45B8-8175-3C050E7AC58A Q40539825-E9F576B3-0148-4689-9C5C-649BBE9A40CE Q40602826-FBBBDD35-4E6F-4A5A-810D-F284ACB263F3 Q45241698-9DC45F74-543E-4C87-A074-922F0B8C3D55 Q47093770-051F6B3A-A6C9-40A9-9CFD-99BE992D54C1 Q47102338-01DE4B8D-3BA2-4421-9395-200BDEBB386F Q52579155-C438882F-83AA-4D88-9AB2-2FCB147C5FE9 Q52668621-D1F017CD-4ECF-4F70-B4D8-E87511F07192 Q54123125-19554EDD-451E-4F01-8A06-517D33B4097B Q55381850-0E3C6644-C82B-4DCE-B1ED-6919B58454DF Q55435803-DE7D5545-5972-481B-AFBF-D19958CBC787 Q55662034-EF658D5C-096F-42D1-A471-E61AABEEFC69 Q57490857-059933F1-2ED3-4E7A-85BE-510442D7189E

P2860

Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.

http://www.wikidata.org/entity/Q36379309

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@ast

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@en

type

label

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@ast

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@en

prefLabel

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@ast

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@en

P1433

Q36379309-B7FB731F-525F-42BB-A7AE-E9DB24EAF665

P1476

Q36379309-4BA5484E-5701-4926-8808-ECFFF472F24F

P2093

Q36379309-2EDA5D25-43CA-4877-A090-77201FD202E5

Q36379309-4FA39299-94B5-4ED0-829A-0D8F59F52BA1

Q36379309-545024AA-C72C-4B70-A841-036DD529FFBB

Q36379309-A82ABFC7-9A0E-4EF3-B1E2-66B0EE516CFB

Q36379309-AF6D119B-B2F0-4EC4-AD74-09079ADB90C0

P2860

Q36379309-0B436D85-4C87-48CA-A4C1-CFA97E9931AF

Q36379309-152F2F2F-C21D-4158-BC7A-CAF027C0A8CB

Q36379309-16473A88-81E2-4FCB-BCE0-D8D2DF12FE91

Q36379309-1C6A99E4-20BB-43C5-A020-C79A43A4E30E

Q36379309-252F4E98-EF2F-4584-A4A7-4C92131C566A

Q36379309-3640B686-48D6-48AA-AA9F-7A1FD45B9D47

Q36379309-37C2DFC6-0777-485B-A29A-7EF2156AF28E

Q36379309-3C20EC0E-9608-42F2-A9E3-36690C09CBE7

Q36379309-3FA2D219-0A14-4661-A875-AF24F93CD838

Q36379309-481A03BD-DDF3-4E71-9988-76A1A7744ECC

P304

Q36379309-A4AFE935-D29D-428B-BCF5-DD0AC276BBD8

P31

Q36379309-12B45D68-1C83-418C-B16E-EB25C49A4B08

P356

Q36379309-D520367B-9CE8-4FBC-B19B-5FE548A0F385

P407

Q36379309-39C37823-69DE-4C35-93A1-EA87E8401A30

P433

Q36379309-2500A05F-A068-4504-BEF0-50F4521783D2

P478

Q36379309-65C6337C-ED78-4E78-8102-72FAF49DC7BF

P50

Q36379309-3C93B416-EAE7-4305-BEB0-6417858D42B6

Q36379309-86D8E789-DC5E-4D08-A04A-9440688AF596

Q36379309-FE007A70-60CB-4CCD-BD2B-B0D10A734039

P577

Q36379309-251ECB9E-5496-4390-8FEC-7E198F5D5D65

P5875

Q36379309-279C9BD6-87C7-46BC-8CE7-8D7E04FC035F

P698

Q36379309-CF3245C0-B11F-43A0-8A18-0E0DECE6ED18

P921

Q36379309-8E16F2E2-5354-4A57-A66F-828DE014E9C1

P932

Q36379309-D69CCB08-85EC-4C20-B310-3A17415DEBF8

P356

P1433

The Journal of Infectious Diseases

P1476

Interleukin-7 ameliorates immu ...... 2-hit model of fungal sepsis.

@en

P2093

Jacqueline Unsinger

http://www.w3.org/2001/XMLSchema#string

Jacquelyn McDonough

http://www.w3.org/2001/XMLSchema#string

Michel Morre

http://www.w3.org/2001/XMLSchema#string

Priya S Prakash

http://www.w3.org/2001/XMLSchema#string

W Michael Dunne

http://www.w3.org/2001/XMLSchema#string

P2860

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

The pathophysiology and treatment of sepsis

Deaths: final data for 1998.

Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.

IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Homing and cellular traffic in lymph nodes.

Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

P304

606-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIS383

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P50

Carey-Ann D Burnham

Charles C. Caldwell

Richard S Hotchkiss

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225301785

http://www.w3.org/2001/XMLSchema#string

P698

22693226

http://www.w3.org/2001/XMLSchema#string

P921

P932

3491749

http://www.w3.org/2001/XMLSchema#string